Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
Authors
Keywords
Cancer treatment, Radiation therapy, Toxicity, Lung and intrathoracic tumors, Hemorrhage, Phase II clinical investigation, Secondary lung tumors, Lymph nodes
Journal
PLoS One
Volume 7, Issue 6, Pages e36979
Publisher
Public Library of Science (PLoS)
Online
2012-06-28
DOI
10.1371/journal.pone.0036979
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
- (2009) Y. Lee et al. BLOOD
- Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases
- (2009) Johnny Kao et al. CANCER
- HPV-induced oropharyngeal cancer, immune response and response to therapy
- (2009) Ha Linh Vu et al. CANCER LETTERS
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
- (2009) Mark T. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- (2009) R. L. Wahl et al. JOURNAL OF NUCLEAR MEDICINE
- Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
- (2009) Youjin Je et al. LANCET ONCOLOGY
- An Initial Report of a Radiation Dose-Escalation Trial in Patients with One to Five Sites of Metastatic Disease
- (2008) J. K. Salama et al. CLINICAL CANCER RESEARCH
- A rationale for the targeted treatment of oligometastases with radiotherapy
- (2008) Dhara M. MacDermed et al. JOURNAL OF SURGICAL ONCOLOGY
- Normal tissue toxicity after small field hypofractionated stereotactic body radiation
- (2008) Michael T Milano et al. Radiation Oncology
- A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions
- (2007) Michael T. Milano et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now